Literature DB >> 4039424

Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy: a clue to etiology?

J M Florence, P T Fox, G J Planer, M H Brooke.   

Abstract

Large and seemingly random fluctuations in the serum levels of creatine kinase (CK) and myoglobin (Mb) have been noted in patients with Duchenne muscular dystrophy. We studied seven affected boys, aged 2 to 9 years. Blood was drawn for CK and Mb every 4 hours, and the boys' activity was documented hourly for 4 days. There was a close correlation between serum levels of CK and Mb with physical activity. Fluctuations in serum levels of CK and Mb are not random and may result from an abnormality of fatty acid metabolism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4039424     DOI: 10.1212/wnl.35.5.758

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Variable cytoplasmic actin expression impacts the sensitivity of different dystrophin-deficient mdx skeletal muscles to eccentric contraction.

Authors:  Angus Lindsay; William M Southern; Preston M McCourt; Alexie A Larson; James S Hodges; Dawn A Lowe; James M Ervasti
Journal:  FEBS J       Date:  2019-04-11       Impact factor: 5.542

2.  Safety and feasibility of high-pressure transvenous limb perfusion with 0.9% saline in human muscular dystrophy.

Authors:  Zheng Fan; Keith Kocis; Robert Valley; James F Howard; Manisha Chopra; Hongyu An; Weili Lin; Joseph Muenzer; William Powers
Journal:  Mol Ther       Date:  2011-07-19       Impact factor: 11.454

3.  Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers.

Authors:  O Tutdibi; H Brinkmeier; R Rüdel; K J Föhr
Journal:  J Physiol       Date:  1999-03-15       Impact factor: 5.182

4.  Null mutation of gp91phox reduces muscle membrane lysis during muscle inflammation in mice.

Authors:  Hal X Nguyen; James G Tidball
Journal:  J Physiol       Date:  2003-10-10       Impact factor: 5.182

5.  Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy.

Authors:  Hideya Mizuno; Akinori Nakamura; Yoshitsugu Aoki; Naoki Ito; Soichiro Kishi; Kazuhiro Yamamoto; Masayuki Sekiguchi; Shin'ichi Takeda; Kazuo Hashido
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

Review 6.  Effect of exercise on serum enzyme activities in humans.

Authors:  T D Noakes
Journal:  Sports Med       Date:  1987 Jul-Aug       Impact factor: 11.136

7.  Rhabdomyolysis in hypokalaemic periodic paralysis: a clue to the mechanism that terminates the paralytic attack?

Authors:  J De Keyser; J Smitz; R Malfait; G Ebinger
Journal:  J Neurol       Date:  1987-02       Impact factor: 4.849

Review 8.  Ataluren as an agent for therapeutic nonsense suppression.

Authors:  Stuart W Peltz; Manal Morsy; Ellen M Welch; Allan Jacobson
Journal:  Annu Rev Med       Date:  2012-11-28       Impact factor: 13.739

9.  High-Pressure Transvenous Perfusion of the Upper Extremity in Human Muscular Dystrophy: A Safety Study with 0.9% Saline.

Authors:  Zheng Fan; Keith Kocis; Robert Valley; James F Howard; Manisha Chopra; Yasheng Chen; Hongyu An; Weili Lin; Joseph Muenzer; William Powers
Journal:  Hum Gene Ther       Date:  2015-07-30       Impact factor: 5.695

Review 10.  Our trails and trials in the subsarcolemmal cytoskeleton network and muscular dystrophy researches in the dystrophin era.

Authors:  Eijiro Ozawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.